US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 1.870
  • +0.030+1.63%
Close Dec 20 16:00 ET
  • 1.900
  • +0.030+1.60%
Post 17:42 ET
392.09MMarket Cap-1.21P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.56%-44.12M
-2.80%-63.59M
16.12%-55.9M
-7.81%-237.73M
13.51%-53.71M
-16.53%-55.53M
-45.44%-61.86M
2.34%-66.64M
-19.32%-220.52M
-36.67%-62.1M
Net income from continuing operations
-6.43%-66.29M
16.25%-66.36M
34.98%-65M
3.86%-327.27M
16.42%-85.78M
25.09%-62.29M
-5.94%-79.23M
-25.19%-99.97M
-86.99%-340.41M
-119,436.05%-102.63M
Operating gains losses
-54.57%1.13M
-115.40%-375K
-68.35%929K
-17.16%10.67M
-68.56%2.81M
51.27%2.5M
263.31%2.44M
-22.76%2.94M
214.99%12.88M
283.99%8.92M
Depreciation and amortization
-10.22%3.21M
0.03%3.64M
1.37%3.56M
-0.67%14.2M
13.33%3.48M
-7.46%3.57M
-0.87%3.64M
-5.01%3.51M
36.74%14.3M
-27.68%3.07M
Other non cash items
-6.07%4.3M
-170.59%-96K
-136.90%-69K
-75.14%579K
-3,277.21%-4.32M
727.67%4.58M
-88.42%136K
-59.87%187K
103.18%2.33M
100.18%136K
Change In working capital
54.00%-8.88M
-284.26%-16.75M
-159.84%-4.44M
-492.74%-15.31M
-91.55%930K
-347.82%-19.3M
-185.49%-4.36M
137.12%7.42M
112.20%3.9M
33,242.42%11M
-Change in prepaid assets
-115.57%-341K
-1,930.39%-1.87M
-106.81%-86K
-56.85%1.09M
-146.34%-2.47M
-61.61%2.19M
105.54%102K
118.93%1.26M
-21.32%2.52M
-0.45%5.33M
-Change in payables and accrued expense
71.83%-4.7M
233.39%5.83M
-186.13%-5.81M
-316.44%-14.32M
-100.21%-13K
-663.81%-16.68M
-161.22%-4.37M
170.59%6.74M
129.36%6.62M
226.25%6.08M
-Change in other current assets
501.37%1.47M
777.00%677K
3,111.11%1.45M
56.36%-1.46M
-740.65%-1.03M
10.29%-366K
-132.15%-100K
101.45%45K
-416.10%-3.33M
-135.65%-123K
-Change in other current liabilities
1,816.67%115K
720.00%41K
101.28%8K
67.53%-611K
-98.10%4K
101.15%6K
100.53%5K
1.42%-626K
-306.81%-1.88M
117.77%210K
-Change in other working capital
---5.42M
----
----
85.71%-3K
1,012.11%4.44M
----
----
82.35%-3K
99.95%-21K
-247.58%-487K
Cash from discontinued investing activities
Operating cash flow
20.56%-44.12M
-2.80%-63.59M
16.12%-55.9M
-7.81%-237.73M
13.51%-53.71M
-16.53%-55.53M
-45.44%-61.86M
2.34%-66.64M
-19.32%-220.52M
-36.67%-62.1M
Investing cash flow
Cash flow from continuing investing activities
-121.76%-75.99M
334.81%74.61M
-80.40%22.13M
53.82%163.29M
36.02%67.46M
-237.59%-34.27M
-68.24%17.16M
604.69%112.94M
-35.13%106.16M
69.56%49.6M
Net PPE purchase and sale
-3,475.00%-429K
--0
99.23%-8K
70.80%-1.52M
89.30%-181K
94.62%-12K
79.04%-288K
45.58%-1.04M
75.80%-5.19M
-129.89%-1.69M
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
-120.59%-75.56M
327.63%74.61M
-80.57%22.14M
48.01%164.81M
31.88%67.64M
-236.32%-34.26M
-68.51%17.45M
656.63%113.97M
-45.10%111.35M
61.50%51.29M
Cash from discontinued investing activities
Investing cash flow
-121.76%-75.99M
334.81%74.61M
-80.40%22.13M
53.82%163.29M
36.02%67.46M
-237.59%-34.27M
-68.24%17.16M
604.69%112.94M
-35.13%106.16M
69.56%49.6M
Financing cash flow
Cash flow from continuing financing activities
-84.15%679K
21.31%108.6M
-4.68%1.65M
3,143.90%95.7M
236.96%155K
301.97%4.29M
372,916.67%89.52M
-4.58%1.73M
-75.34%2.95M
-85.71%46K
Net common stock issuance
--0
----
----
--91.11M
--0
--3.19M
----
----
--0
--0
Proceeds from stock option exercised by employees
-37.76%679K
-98.82%19K
-4.68%1.65M
55.36%4.58M
236.96%155K
2.35%1.09M
6,591.67%1.61M
-4.58%1.73M
-75.34%2.95M
-85.71%46K
Net other financing activities
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-84.15%679K
21.31%108.6M
-4.68%1.65M
3,143.90%95.7M
236.96%155K
301.97%4.29M
372,916.67%89.52M
-4.58%1.73M
-75.34%2.95M
-85.71%46K
Net cash flow
Beginning cash position
9.64%180.96M
-48.99%61.33M
29.44%93.45M
-60.68%72.2M
-6.04%79.54M
55.22%165.05M
26.81%120.22M
-60.68%72.2M
-4.77%183.61M
-57.56%84.65M
Current changes in cash
-39.66%-119.43M
166.87%119.63M
-166.87%-32.12M
119.07%21.25M
211.69%13.91M
-294.36%-85.51M
288.89%44.83M
154.08%48.03M
-1,111.77%-111.41M
21.50%-12.45M
End cash Position
-22.64%61.53M
9.64%180.96M
-48.99%61.33M
29.44%93.45M
29.44%93.45M
-6.04%79.54M
55.22%165.05M
26.81%120.22M
-60.68%72.2M
-60.68%72.2M
Free cash flow
19.80%-44.54M
-2.32%-63.59M
17.39%-55.91M
-6.00%-239.25M
15.52%-53.89M
-16.01%-55.54M
-41.54%-62.15M
3.51%-67.67M
-9.43%-225.71M
-38.15%-63.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.56%-44.12M-2.80%-63.59M16.12%-55.9M-7.81%-237.73M13.51%-53.71M-16.53%-55.53M-45.44%-61.86M2.34%-66.64M-19.32%-220.52M-36.67%-62.1M
Net income from continuing operations -6.43%-66.29M16.25%-66.36M34.98%-65M3.86%-327.27M16.42%-85.78M25.09%-62.29M-5.94%-79.23M-25.19%-99.97M-86.99%-340.41M-119,436.05%-102.63M
Operating gains losses -54.57%1.13M-115.40%-375K-68.35%929K-17.16%10.67M-68.56%2.81M51.27%2.5M263.31%2.44M-22.76%2.94M214.99%12.88M283.99%8.92M
Depreciation and amortization -10.22%3.21M0.03%3.64M1.37%3.56M-0.67%14.2M13.33%3.48M-7.46%3.57M-0.87%3.64M-5.01%3.51M36.74%14.3M-27.68%3.07M
Other non cash items -6.07%4.3M-170.59%-96K-136.90%-69K-75.14%579K-3,277.21%-4.32M727.67%4.58M-88.42%136K-59.87%187K103.18%2.33M100.18%136K
Change In working capital 54.00%-8.88M-284.26%-16.75M-159.84%-4.44M-492.74%-15.31M-91.55%930K-347.82%-19.3M-185.49%-4.36M137.12%7.42M112.20%3.9M33,242.42%11M
-Change in prepaid assets -115.57%-341K-1,930.39%-1.87M-106.81%-86K-56.85%1.09M-146.34%-2.47M-61.61%2.19M105.54%102K118.93%1.26M-21.32%2.52M-0.45%5.33M
-Change in payables and accrued expense 71.83%-4.7M233.39%5.83M-186.13%-5.81M-316.44%-14.32M-100.21%-13K-663.81%-16.68M-161.22%-4.37M170.59%6.74M129.36%6.62M226.25%6.08M
-Change in other current assets 501.37%1.47M777.00%677K3,111.11%1.45M56.36%-1.46M-740.65%-1.03M10.29%-366K-132.15%-100K101.45%45K-416.10%-3.33M-135.65%-123K
-Change in other current liabilities 1,816.67%115K720.00%41K101.28%8K67.53%-611K-98.10%4K101.15%6K100.53%5K1.42%-626K-306.81%-1.88M117.77%210K
-Change in other working capital ---5.42M--------85.71%-3K1,012.11%4.44M--------82.35%-3K99.95%-21K-247.58%-487K
Cash from discontinued investing activities
Operating cash flow 20.56%-44.12M-2.80%-63.59M16.12%-55.9M-7.81%-237.73M13.51%-53.71M-16.53%-55.53M-45.44%-61.86M2.34%-66.64M-19.32%-220.52M-36.67%-62.1M
Investing cash flow
Cash flow from continuing investing activities -121.76%-75.99M334.81%74.61M-80.40%22.13M53.82%163.29M36.02%67.46M-237.59%-34.27M-68.24%17.16M604.69%112.94M-35.13%106.16M69.56%49.6M
Net PPE purchase and sale -3,475.00%-429K--099.23%-8K70.80%-1.52M89.30%-181K94.62%-12K79.04%-288K45.58%-1.04M75.80%-5.19M-129.89%-1.69M
Net business purchase and sale --------------0------------------0----
Net investment purchase and sale -120.59%-75.56M327.63%74.61M-80.57%22.14M48.01%164.81M31.88%67.64M-236.32%-34.26M-68.51%17.45M656.63%113.97M-45.10%111.35M61.50%51.29M
Cash from discontinued investing activities
Investing cash flow -121.76%-75.99M334.81%74.61M-80.40%22.13M53.82%163.29M36.02%67.46M-237.59%-34.27M-68.24%17.16M604.69%112.94M-35.13%106.16M69.56%49.6M
Financing cash flow
Cash flow from continuing financing activities -84.15%679K21.31%108.6M-4.68%1.65M3,143.90%95.7M236.96%155K301.97%4.29M372,916.67%89.52M-4.58%1.73M-75.34%2.95M-85.71%46K
Net common stock issuance --0----------91.11M--0--3.19M----------0--0
Proceeds from stock option exercised by employees -37.76%679K-98.82%19K-4.68%1.65M55.36%4.58M236.96%155K2.35%1.09M6,591.67%1.61M-4.58%1.73M-75.34%2.95M-85.71%46K
Net other financing activities --0------------------------------------
Cash from discontinued financing activities
Financing cash flow -84.15%679K21.31%108.6M-4.68%1.65M3,143.90%95.7M236.96%155K301.97%4.29M372,916.67%89.52M-4.58%1.73M-75.34%2.95M-85.71%46K
Net cash flow
Beginning cash position 9.64%180.96M-48.99%61.33M29.44%93.45M-60.68%72.2M-6.04%79.54M55.22%165.05M26.81%120.22M-60.68%72.2M-4.77%183.61M-57.56%84.65M
Current changes in cash -39.66%-119.43M166.87%119.63M-166.87%-32.12M119.07%21.25M211.69%13.91M-294.36%-85.51M288.89%44.83M154.08%48.03M-1,111.77%-111.41M21.50%-12.45M
End cash Position -22.64%61.53M9.64%180.96M-48.99%61.33M29.44%93.45M29.44%93.45M-6.04%79.54M55.22%165.05M26.81%120.22M-60.68%72.2M-60.68%72.2M
Free cash flow 19.80%-44.54M-2.32%-63.59M17.39%-55.91M-6.00%-239.25M15.52%-53.89M-16.01%-55.54M-41.54%-62.15M3.51%-67.67M-9.43%-225.71M-38.15%-63.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data